But multinational pharmaceutical company says it offered government solutions.

Older adults and analytical thinkers excel at discerning true from false news, while ideological biases and political identity shape misinformation susceptibility in distinct ways.

A coronial inquiry is being held at Hastings District Court to decide which issues will be considered by the coroner looking into the 12 deaths caused by the cyclone.

Nasser, a resident of Lakshadweep islands, touches upon the crux of one of the most concerning problems of our times – climate change. With islands being among the most vulnerable systems to the adverse impacts of accelerated climate change, it’s people like him, often for no fault of theirs, that find their lives and livelihoods threatened. And yet, more than often, islanders have displayed extreme resilience and continued to practice their sustainable ways more or less.  

Nations return to deadlocked UN climate talks, with hopes that G20 leaders meeting on the other side of the world can rally support behind a deal for poorer countries.

Lisa Sherrington, 50, died from an inflammation of the brain caused by the herpes virus

While the festive season is a happy time for many, it can also exacerbate symptoms of dementia and families will be more likely to notice

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a fifth-generation (v5) eVLP with enhanced production, transduction, and gene-editing efficiency. This system could pave the way for improved gene delivery vehicles in therapeutic applications.

Researchers review the biological activities of growth hormone-releasing hormone and its analogs.

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR T-cells. This breakthrough enhances tumor targeting while reducing off-target effects, paving the way for advanced synthetic biology applications.

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk triple-negative breast cancer patients.